GENEVA - The World Health Organization said Friday it has signed a purchase agreement for up to 40 million doses of the coronavirus vaccine developed by U.S. pharmaceutical giant Pfizer Inc. as part of its initiative to provide global equitable access to COVID-19 vaccines.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
